INFORMATION RÉGLEMENTÉE
Publication relative à des notifications de transparence
Read more »
Nyxoah Annonce le Lancement Commercial de la Thérapie Innovante Genio® en Angleterre
Nyxoah Annonce le Lancement Commercial de la Thérapie Innovante Genio® en Angleterre
Nyxoah Annonce le Lancement Commercial de la Thérapie [...] Read more »
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England
First patients implanted with Genio at UCLH, London
Read more »
Informations sur le nombre total de droits de vote et d'actions
Informations sur le nombre total de droits de vote et d'actions
INFORMATION RÉGLEMENTÉE
Informations [...] Read more »
Information on the total number of voting rights and shares
REGULATED INFORMATION
Information on the total number of voting rights and shares
Mont–Saint–Guibert [...] Read more »
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
Mont–Saint–Guibert, Belgium – [...] Read more »
Nyxoah Participera à la Piper Sandler 36th Annual Healthcare Conference
Nyxoah Participera à la Piper Sandler 36th Annual Healthcare Conference
Nyxoah Participera à la Piper Sandler [...] Read more »
Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024
REGULATED INFORMATION
November 19, 2024, 7:00am CET / 1:00am ET
NYXOAH SA
(Euronext Brussels/Nasdaq: NYXH)
Rue Edouard Belin 12, 1435 [...] Read more »
Invitation à assister à l'assemblée générale spéciale des actionnaires de la Société qui se tiendra le 19 décembre 2024
INFORMATIONS RÉGLEMENTÉES
le 19 novembre 2024, 7:00h CET / 1:00h ET
NYXOAH SA
(Euronext Brussels/Nasdaq: NYXH)
Rue Edouard Belin 12, 1435 [...] Read more »
Publication relating to transparency notifications
REGULATED INFORMATION
Publication relating to transparency notifications
Read more »